GrandVision missed earnings forecasts for its second quarter, largely due to the implementation of French legislation that has imposed ceilings on health insurance reimbursements. The company's adjusted core profits dropped by 6.4 percent to €140 million, well below a consensus estimate by financial analysts of €155 million.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
To continue reading this article register now.